TCR Biotherapeutics
TCR Biotherapeutics is a preclinical biotechnology company focused on transforming the lives of patients burdened with severe and life-threatening autoimmune diseases. We are developing a next-generation pipeline of off-the-shelf and universally compatible therapeutics derived from T Cell receptors (TCR) with the goal of treating autoimmune disease and graft-versus-host disease (GVHD). Based in Milwaukee, Wisconsin, TCR Biotherapeutics is currently conducting preclinical work ahead of first-in-human clinical trials.